🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Novo Nordisk A/S — Licensed Medicines

129 medicines held by Novo Nordisk A/S on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 129 products held by Novo Nordisk A/S
MedicineActive substanceLicence holderStatus
NovoNorm 1 mg tablets
EU/1/98/076/013
Repaglinide Novo Nordisk A/S
NovoNorm 1 mg tablets
EU/1/98/076/014
Repaglinide Novo Nordisk A/S
NovoNorm 2 mg tablets
EU/1/98/076/018
Repaglinide Novo Nordisk A/S
NovoNorm 2 mg tablets
EU/1/98/076/019
Repaglinide Novo Nordisk A/S
NovoNorm 2 mg tablets
EU/1/98/076/020
Repaglinide Novo Nordisk A/S
NovoNorm 2 mg tablets
EU/1/98/076/021
Repaglinide Novo Nordisk A/S
NovoRapid 100 U/ml Solution for injection
EU/1/99/119/001
Insulin aspart Novo Nordisk A/S
NovoRapid FlexPen 100 U/ml Solution for injection
EU/1/99/119/009-011
Insulin aspart Novo Nordisk A/S
NovoRapid FlexTouch 100 U/ml Solution for injection
EU/1/99/119/019
Insulin aspart Novo Nordisk A/S
NovoRapid InnoLet 100 U/ml Solution for injection
EU/1/99/119/012-014
Insulin aspart Novo Nordisk A/S
NovoRapid Penfill 100 U/ml Solution for injection
EU/1/99/119/003
Insulin aspart Novo Nordisk A/S
NovoRapid PumpCart 100 U/ml Solution for injection
EU/1/99/119/024-025
Insulin aspart Novo Nordisk A/S
NovoSeven (400 KIU)
EU/1/96/006/007
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (100 KIU)
EU/1/96/006/005
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (100 KIU)
EU/1/96/006/009
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (250 KIU)
EU/1/96/006/006
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (250 KIU)
EU/1/96/006/010
Eptacog alfa (activated) Novo Nordisk A/S
Novoseven (400 KIU)
EU/1/96/006/011
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (50 KIU)
EU/1/96/006/004
Eptacog alfa (activated) Novo Nordisk A/S
NovoSeven (50 KIU)
EU/1/96/006/008
Eptacog alfa (activated) Novo Nordisk A/S
NovoThirteen 2500 IU powder and solvent for solution for injection
EU/1/12/775/001
Rfxiii drug substance Novo Nordisk A/S
Ozempic 0.25 mg solution for injection in pre-filled pen
EU/1/17/1251/002
Semaglutide Novo Nordisk A/S
Ozempic 0.5 mg solution for injection in pre-filled pen
EU/1/17/1251/003-004
Semaglutide Novo Nordisk A/S
Ozempic 0.5 mg solution for injection in pre-filled pen
EU/1/17/1251/012-013
Semaglutide Novo Nordisk A/S
Ozempic 1 mg solution for injection in pre-filled pen
EU/1/17/1251/005-006
Semaglutide Novo Nordisk A/S
Ozempic 2 mg solution for injection in pre-filled pen
EU/1/17/1251/010-011
Semaglutide Novo Nordisk A/S
Prandin
EU/1/00/162/002
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/003
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/004
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/005
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/006
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/007
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/008
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/009
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/010
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/011
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/012
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/013
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/014
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/015
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/016
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/017
Repaglinide Novo Nordisk A/S
Prandin
EU/1/00/162/018
Repaglinide Novo Nordisk A/S
PRANDIN
EU/1/00/162/001
Repaglinide Novo Nordisk A/S
Protaphane
EU/1/02/234/016-017
Insulin human Novo Nordisk A/S
Protaphane
EU/1/02/234/1-15
Insulin human Novo Nordisk A/S
Refixia 1 000 IU powder and solvent for solution for injection
EU/1/17/1193/002
Nonacog beta pegol Novo Nordisk A/S
Refixia 2 000 IU powder and solvent for solution for injection
EU/1/17/1193/003
Nonacog beta pegol Novo Nordisk A/S
Refixia 3 000 IU powder and solvent for solution for injection
EU/1/17/1193/004
Nonacog beta pegol Novo Nordisk A/S
Refixia 500 IU powder and solvent for solution for injection
EU/1/17/1193/001
Nonacog beta pegol Novo Nordisk A/S
1 2 3
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.